Piramal Pharma Limited gibt Ergebnisse für das dritte Quartal und die ersten neun Monate des Geschäftsjahres 2026 bekannt

MUMBAI, Indien, 30. Januar 2026 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), ein weltweit führendes Pharma-, Gesundheits- und Wellnessunternehmen, gab heute seine Einzel- und Konzernergebnisse für das dritte Quartal (Q3) und die ersten neun Monate (9M) zum 31. Dezember 2025 bekannt. Wichtige Finanzergebnisse im Konzernabschluss (in Milliarden INR oder wie angegeben) Einzelheiten Q3FY26 Q3FY25 %… Continue reading Piramal Pharma Limited gibt Ergebnisse für das dritte Quartal und die ersten neun Monate des Geschäftsjahres 2026 bekannt

Aquaporin announces withdrawal of its offering and resolves to initiate insolvency proceedings

Company announcement  No. 04/2026 Inside information Aquaporin A/S Nymøllevej 78 DK-2800 Kongens Lyngby aquaporin.com Company registration no.: DK28315694 KONGENS LYNGBY, Denmark, Jan. 30, 2026 /PRNewswire/ — The Board of Directors of Aquaporin A/S (“Aquaporin” or the “Company“) has today decided to withdraw the rights issue that was announced on December 19, 2025 (the “Rights Issue”… Continue reading Aquaporin announces withdrawal of its offering and resolves to initiate insolvency proceedings

Aquaporin announces withdrawal of its offering and resolves to initiate insolvency proceedings

Company announcement  No. 04/2026 Inside information Aquaporin A/S Nymøllevej 78 DK-2800 Kongens Lyngby aquaporin.com Company registration no.: DK28315694 KONGENS LYNGBY, Denmark, Jan. 30, 2026 /PRNewswire/ — The Board of Directors of Aquaporin A/S (“Aquaporin” or the “Company“) has today decided to withdraw the rights issue that was announced on December 19, 2025 (the “Rights Issue”… Continue reading Aquaporin announces withdrawal of its offering and resolves to initiate insolvency proceedings

DentScribe Introduces “Talk Like You Always Do” AI Voice Perio Charting: Perio Findings Convert to Treatments and Revenue

SUNNYVALE, Calif., Jan. 30, 2026 /PRNewswire/ — Perio charting shouldn’t feel like operating a voice command system. It should feel like a clinical exam: probe, speak, and move on, all without losing rapport with the patient. Today, DentScribe announced DentScribe AI Voice Perio Charting, a patent-pending capability that enables hygienists and dentists to chart perio hands-free by… Continue reading DentScribe Introduces “Talk Like You Always Do” AI Voice Perio Charting: Perio Findings Convert to Treatments and Revenue

SKF Q4 2025: Laying the foundation for long-term value creation

GOTHENBURG, Sweden, Jan. 30, 2026 /PRNewswire/ — Q4 2025 Net sales: MSEK 21,969 (24,725) Organic growth: 0.0% (−3.1%), driven by organic sales growth within the Industrial business, offset by negative market demand for the Automotive business. Adjusted operating profit: MSEK 2,588 (2,735). Strong positive cost development and solid price/mix contribution nearly offset lower volumes and significant… Continue reading SKF Q4 2025: Laying the foundation for long-term value creation

SKF Q4 2025: Laying the foundation for long-term value creation

GOTHENBURG, Sweden, Jan. 30, 2026 /PRNewswire/ — Q4 2025 Net sales: MSEK 21,969 (24,725) Organic growth: 0.0% (−3.1%), driven by organic sales growth within the Industrial business, offset by negative market demand for the Automotive business. Adjusted operating profit: MSEK 2,588 (2,735). Strong positive cost development and solid price/mix contribution nearly offset lower volumes and significant… Continue reading SKF Q4 2025: Laying the foundation for long-term value creation

World Gym Corporation Presents at 2026 ICR Conference

Company Management Explores Public Listing in the U.S. and Highlights Launch of New Biomarker Tech Integration   TAIPEI, Jan. 30, 2026 /PRNewswire/ — World Gym Corporation (2762.TW) (“World Gym ” or the “Company”), the owner of the iconic World Gym brand with over 280 locations worldwide, recently presented at the 28th Annual ICR Conference, one… Continue reading World Gym Corporation Presents at 2026 ICR Conference

Tetragon Financial Group Limited December 2025 Monthly Factsheet

LONDON, Jan. 30, 2026 /PRNewswire/ — Tetragon has released its Monthly Factsheet for December 2025. Net Asset Value: $3,892m Fully Diluted NAV per Share: $41.88 Share Price (TFG NA): $17.35 Monthly NAV per Share Total Return: 0.1% Monthly Return on Equity: 0.5% Most Recent Quarterly Dividend: $0.11 Dividend Yield: 2.6% Please refer to important disclosures on… Continue reading Tetragon Financial Group Limited December 2025 Monthly Factsheet

Electrolux Group Year-end report Q4 2025

STOCKHOLM, Jan. 30, 2026 /PRNewswire/ — Highlights of the fourth quarter of 2025 Net sales amounted to SEK 35,112m (37,968) with an organic sales growth of 2.0% (11.5), driven by higher sales volumes and positive mix. Operating income improved to SEK 1,517m (1,052) corresponding to an operating margin of 4.3% (2.8). The increase was driven… Continue reading Electrolux Group Year-end report Q4 2025

Electrolux Group Year-end report Q4 2025

STOCKHOLM, Jan. 30, 2026 /PRNewswire/ — Highlights of the fourth quarter of 2025 Net sales amounted to SEK 35,112m (37,968) with an organic sales growth of 2.0% (11.5), driven by higher sales volumes and positive mix. Operating income improved to SEK 1,517m (1,052) corresponding to an operating margin of 4.3% (2.8). The increase was driven… Continue reading Electrolux Group Year-end report Q4 2025